Supriya Lifescience Limited (NSE:SUPRIYA)
India · Delayed Price · Currency is INR 895.55
-21.70 (-2.37%)
Jun 3, 2026, 11:50 AM IST
Supriya Lifescience Market Cap
Supriya Lifescience has a market cap or net worth of 73.82 billion as of June 2, 2026. Its market cap has increased by 38.07% in one year.
Market Cap
73.82B
Enterprise Value
73.09B
Revenue
8.28B
Ranking
n/a
PE Ratio
35.31
Stock Price
895.55
Market Cap Chart
Since December 28, 2021, Supriya Lifescience's market cap has increased from 31.46B to 73.82B, an increase of 134.68%. That is a compound annual growth rate of 21.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 73.82B | 22.06% |
| Dec 31, 2025 | 60.48B | 1.58% |
| Dec 31, 2024 | 59.54B | 135.04% |
| Dec 29, 2023 | 25.33B | 33.91% |
| Dec 30, 2022 | 18.92B | -51.41% |
| Dec 31, 2021 | 38.93B | 23.76% |
| Dec 28, 2021 | 31.46B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocon | 693.71B |
| Anthem Biosciences | 426.80B |
| OneSource Specialty Pharma | 209.18B |
| Concord Biotech | 109.97B |
| Blue Jet Healthcare | 77.95B |
| Zota Health Care | 38.97B |
| Dishman Carbogen Amcis | 30.53B |
| Panacea Biotec | 25.29B |